SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) SynCon(TM) Universal Influenza DNA Vaccine Technology Recognized with National Institutes of Health (NIH) Director's Transformative Research Award